Impact of ibrutinib dose adherence on therapeutic efficacy in patients with previously treated CLL/SLL.
暂无分享，去创建一个
J. Byrd | U. Jaeger | C. Dearden | S. Mulligan | S. O'brien | J. Pagel | Jennifer R. Brown | J. Burger | T. Robak | M. Montillo | S. Coutre | R. Furman | J. Sukbuntherng | P. Barr | F. Cymbalista | P. Hillmen | J. Barrientos | N. Reddy | D. James | G. Cole | C. Moreno | S. Suzuki